betamethasone-17,21-dipropionate has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fibeger, E; Milosavljevic, K; Virata, AR | 1 |
| Cary-Ten Have Dallinga, M; El Kouri, C; Lortholary, A; Morineau, N; Ramée, JF | 1 |
| Casanova, JM; Cortada, L; Puig, T; Ramos, J; Rubio, M | 1 |
3 other study(ies) available for betamethasone-17,21-dipropionate and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
A Case of Linear Cutaneous Lupus Erythematosus in a 55-Year-Old Woman.
Topics: Administration, Topical; Age Factors; Anti-Inflammatory Agents; Betamethasone; Exanthema; Female; Forearm; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Midwestern United States; Pruritus; Skin; Sunscreening Agents; Treatment Outcome | 2020 |
[Paclitaxel-induced lupus].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Betamethasone; Biopsy; Drug Therapy, Combination; Erythropoietin; Female; Humans; Lupus Erythematosus, Cutaneous; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Recurrence; Skin; Treatment Outcome | 2007 |
[Subacute cutaneous lupus erythematosus. Treatment with sulfone].
Topics: Acute Disease; Aged; Betamethasone; Humans; Lupus Erythematosus, Cutaneous; Male; Sulfones | 1987 |